Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65years patients with de novo acute myeloid leukemia

The European LeukemiaNet (ELN) recently proposed a revised recommendation for the diagnosis and management of acute myeloid leukemia (AML) in adults, recognized as ELN‐2022. However, validation in a large real‐world cohort remains lacking. In this study, we aimed to validate the prognostic relevance...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hematology 2023-05, Vol.98 (5), p.760-769
Hauptverfasser:	Min‐Yen Lo, Xavier Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yuan‐Yeh Kuo, Wan‐Hsuan Lee, Yen‐Ling Peng, Ming‐Chih Liu, Mei‐Hsuan Tseng, Cheng‐An Hsu, Jui‐Che Chen, Liang‐In Lin, Hsun‐I Sun, Yi‐Kuang Chuang, Bor‐Sheng Ko, Jih‐Luh Tang, Yao, Ming, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Allografts Chemotherapy Hematology Janus kinase 2 Karyotypes Leukemia Mutation Prediction models Remission Remission (Medicine) Risk groups Runx1 protein Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!